Cargando…

Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018

BACKGROUND & AIMS: There are approximately 49,000 people (0.34%) in the Netherlands with a chronic hepatitis B virus (HBV) infection. It is unclear how many are linked to care and under follow-up in hepatitis outpatient clinics. This study determined the cascade of care and identified predictors...

Descripción completa

Detalles Bibliográficos
Autores principales: van Oorschot, Eva, Koc, Özgür M., Oude Lashof, Astrid ML., van Loo, Inge HM., Ackens, Robin, Posthouwer, Dirk, Koek, Ger H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241047/
https://www.ncbi.nlm.nih.gov/pubmed/35784678
http://dx.doi.org/10.1016/j.jve.2022.100075
_version_ 1784737708041568256
author van Oorschot, Eva
Koc, Özgür M.
Oude Lashof, Astrid ML.
van Loo, Inge HM.
Ackens, Robin
Posthouwer, Dirk
Koek, Ger H.
author_facet van Oorschot, Eva
Koc, Özgür M.
Oude Lashof, Astrid ML.
van Loo, Inge HM.
Ackens, Robin
Posthouwer, Dirk
Koek, Ger H.
author_sort van Oorschot, Eva
collection PubMed
description BACKGROUND & AIMS: There are approximately 49,000 people (0.34%) in the Netherlands with a chronic hepatitis B virus (HBV) infection. It is unclear how many are linked to care and under follow-up in hepatitis outpatient clinics. This study determined the cascade of care and identified predictors for not being linked to care and loss to follow-up in Maastricht, the Netherlands. METHODS: All hepatitis B surface antigen (HBsAg)-positive patients between December 1, 1996 and September 30, 2018 were retrospectively identified. RESULTS: In total, 644 HBsAg-positive patients were identified; of whom 75 had acute HBV infection, 471 chronic HBV infection and 98 unknown. Out of 569 individuals with a chronic/unknown HBV status, 134/569 (23.6%) were not linked to care and 58.7% (195/332 after excluding those who died or achieved HBsAg-seroclearance) were loss to follow-up (LTFU). A predictor for not being linked to care was Caucasian ethnicity (odds ratio (OR) = 2.76 (95% Confidence Interval (CI) = 1.21–6.29); p = .015). Predictors for LTFU were older age (OR = 0.97 (CI = 0.94–0.99); p = .008), HBV DNA >20,000 IU/mL (OR = 0.44 (CI = 0.21 - 0.93); p = .033) and Asian ethnicity (OR = 0.46, (CI = 0.21–1.00); p = .050). Rates of not being linked to care and LTFU decreased over time from 12.7% in 1996 to 4.4% in 2018 and from 79.2% in 1996 to 37.2% in 2018, respectively. CONCLUSIONS: A considerable amount of HBsAg-positive individuals were not linked to care or LTFU. This study indicates that ethnicity plays a role in linkage to care and follow-up. Further research is needed to elaborate on those results.
format Online
Article
Text
id pubmed-9241047
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92410472022-06-30 Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018 van Oorschot, Eva Koc, Özgür M. Oude Lashof, Astrid ML. van Loo, Inge HM. Ackens, Robin Posthouwer, Dirk Koek, Ger H. J Virus Erad Original Research BACKGROUND & AIMS: There are approximately 49,000 people (0.34%) in the Netherlands with a chronic hepatitis B virus (HBV) infection. It is unclear how many are linked to care and under follow-up in hepatitis outpatient clinics. This study determined the cascade of care and identified predictors for not being linked to care and loss to follow-up in Maastricht, the Netherlands. METHODS: All hepatitis B surface antigen (HBsAg)-positive patients between December 1, 1996 and September 30, 2018 were retrospectively identified. RESULTS: In total, 644 HBsAg-positive patients were identified; of whom 75 had acute HBV infection, 471 chronic HBV infection and 98 unknown. Out of 569 individuals with a chronic/unknown HBV status, 134/569 (23.6%) were not linked to care and 58.7% (195/332 after excluding those who died or achieved HBsAg-seroclearance) were loss to follow-up (LTFU). A predictor for not being linked to care was Caucasian ethnicity (odds ratio (OR) = 2.76 (95% Confidence Interval (CI) = 1.21–6.29); p = .015). Predictors for LTFU were older age (OR = 0.97 (CI = 0.94–0.99); p = .008), HBV DNA >20,000 IU/mL (OR = 0.44 (CI = 0.21 - 0.93); p = .033) and Asian ethnicity (OR = 0.46, (CI = 0.21–1.00); p = .050). Rates of not being linked to care and LTFU decreased over time from 12.7% in 1996 to 4.4% in 2018 and from 79.2% in 1996 to 37.2% in 2018, respectively. CONCLUSIONS: A considerable amount of HBsAg-positive individuals were not linked to care or LTFU. This study indicates that ethnicity plays a role in linkage to care and follow-up. Further research is needed to elaborate on those results. Elsevier 2022-06-20 /pmc/articles/PMC9241047/ /pubmed/35784678 http://dx.doi.org/10.1016/j.jve.2022.100075 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research
van Oorschot, Eva
Koc, Özgür M.
Oude Lashof, Astrid ML.
van Loo, Inge HM.
Ackens, Robin
Posthouwer, Dirk
Koek, Ger H.
Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018
title Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018
title_full Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018
title_fullStr Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018
title_full_unstemmed Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018
title_short Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018
title_sort cascade of care among hepatitis b patients in maastricht, the netherlands, 1996 to 2018
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241047/
https://www.ncbi.nlm.nih.gov/pubmed/35784678
http://dx.doi.org/10.1016/j.jve.2022.100075
work_keys_str_mv AT vanoorschoteva cascadeofcareamonghepatitisbpatientsinmaastrichtthenetherlands1996to2018
AT kocozgurm cascadeofcareamonghepatitisbpatientsinmaastrichtthenetherlands1996to2018
AT oudelashofastridml cascadeofcareamonghepatitisbpatientsinmaastrichtthenetherlands1996to2018
AT vanlooingehm cascadeofcareamonghepatitisbpatientsinmaastrichtthenetherlands1996to2018
AT ackensrobin cascadeofcareamonghepatitisbpatientsinmaastrichtthenetherlands1996to2018
AT posthouwerdirk cascadeofcareamonghepatitisbpatientsinmaastrichtthenetherlands1996to2018
AT koekgerh cascadeofcareamonghepatitisbpatientsinmaastrichtthenetherlands1996to2018